US Patent 11903959 N4-hydroxycytidine and derivatives and anti-viral uses related thereto

Patent 11903959 was granted and assigned to Emory University on February, 2024 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Current Assignee

Emory University

Date Filed

September 2, 2021

Date of Patent

February 20, 2024

Patent Applicant

Emory University

Patent Application Number

17465344

Patent Citations

‌

US Patent 8236779 Antiviral nucleosides

‌

US Patent 8686045 Methods of facilitating neural cell survival using non-peptide and peptide BDNF neurotrophin mimetics

‌

US Patent 9073960 Substituted nucleosides, nucleotides and analogs thereof

‌

US Patent 9211300 4′-fluoro nucleosides for the treatment of HCV

‌

US Patent 9422321 Pyrimidine nucleoside derivatives, synthesis methods and uses thereof for preparing anti-tumor and anti-virus medicaments

‌

US Patent 9603863 Substituted nucleosides, nucleotides and analogs thereof

‌

US Patent 9603864 Substituted nucleosides, nucleotides and analogs thereof

‌

US Patent 9809616 Pyrimidine nucleosides and their monophosphate prodrugs for the treatment of viral infections and cancer

‌

US Patent 9862743 Substituted nucleosides, nucleotides and analogs thereof

‌

US Patent 9877990 Compositions and methods for the treatment of wounds, disorders, and diseases of the skin

•••

Patent Inventor Names

George R. Painter

Michael G. Natchus

David Guthrie

Gregory R. Bluemling

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

11903959

Patent Primary Examiner

‌

Traviss C Mcintosh, III

Find more entities like US Patent 11903959 N4-hydroxycytidine and derivatives and anti-viral uses related thereto

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API